BioSpecifics Technologies Corp. (BSTC, Financial) filed Quarterly Report for the period ended 2008-03-31.
BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing for sale by other a U.S. Food and Drug Administration (``FDA``) approved enzyme derived from collagenase named Collagenase ABC and researching developing and clinically testing additional products derived therefrom for potential use as pharmaceuticals..
Gurus buys and sells of BSTC
10-year financial history of BSTC.
Insider buys/sells of BSTC.
BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing for sale by other a U.S. Food and Drug Administration (``FDA``) approved enzyme derived from collagenase named Collagenase ABC and researching developing and clinically testing additional products derived therefrom for potential use as pharmaceuticals..
Highlight of Business Operations:
Read the The complete ReportMore on BSTC:Gurus buys and sells of BSTC
10-year financial history of BSTC.
Insider buys/sells of BSTC.
